Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Raptor Pharmaceutical
Raptor Pharmaceutical
Horizon Buys Rare-Disease Company Raptor for $800 Million
Bloomberg
Mon, 09/12/16 - 09:49 am
Horizon Pharma
M&A
Rare Diseases
Raptor Pharmaceutical
Procybi
Quinsair
Four New Patents Issued, PROCYSBI® Granted Additional U.S. Orphan Exclusivity
Yahoo
Mon, 01/25/16 - 10:00 am
procysbi
patents
Raptor Pharmaceutical
orphan drugs
Raptor to advance neurodegenerative disorder drug in registration study
Yahoo/Reuters
Thu, 12/10/15 - 11:36 am
Raptor Pharmaceutical
RP103
Huntington's disease
10 Worst NASDAQ Biotech Stocks in the Third Quarter
TheStreet.com
Wed, 09/30/15 - 07:51 pm
Orexigen
Immunomedics
Celldex Therapeutics
Arena Pharmaceuticals
Theravance
Karyopharm
Raptor Pharmaceutical
Verastem
Tetraphase
Xoma
Raptor Pharmaceutical's Trial Failed, But Huntington's Disease Update Could Bring Gains At Year End
Yahoo/Benzinga
Tue, 09/15/15 - 11:40 am
Raptor Pharmaceutical
RP103
NASH
Huntington's disease
Raptor Pharma says may discontinue development of liver drug
Yahoo/Reuters
Mon, 09/14/15 - 08:23 am
Raptor Pharmaceutical
RP103
NASH
non-alcoholic fatty liver disease
Raptor Pharmaceutical Makes an Acquisition
Investopedia
Wed, 08/26/15 - 09:30 am
Raptor Pharmaceutical
M&A
Quinsair
Tripex
cystic fibrosis